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Background: Financial incentives may improve the initiation and 
engagement of behaviour change that reduce the negative outcomes 
associated with non-communicable diseases. There is still a paucity in 
guidelines or recommendations that help define key aspects of 
incentive-oriented interventions, including the type of incentive (e.g. 
cash rewards, vouchers), the frequency and magnitude of the 
incentive, and its mode of delivery.  We aimed to systematically review 
the literature on financial incentives that promote healthy lifestyle 
behaviours or improve health profiles, and focused on the 
methodological approach to define the incentive intervention and its 
delivery. The protocol was registered at PROSPERO on 26 July 2018 (
CRD42018102556). 
Methods: We sought studies in which a financial incentive was 
delivered to improve a health-related lifestyle behaviour (e.g., physical 
activity) or a health profile (e.g., HbA1c in people with diabetes). The 
search (which took place on March 3rd 2018) was conducted using 
OVID (MEDLINE and Embase), CINAHL and Scopus. 
Results: The search yielded 7,575 results and 37 were included for 
synthesis. Of the total, 83.8% (31/37) of the studies were conducted in 
the US, and 40.5% (15/37) were randomised controlled trials. Only one 
study reported the background and rationale followed to develop the 
incentive and conducted a focus group to understand what sort of 
incentives would be acceptable for their study population. There was a 
degree of consistency across the studies in terms of the direction, 
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form, certainty, and recipient of the financial incentives used, but the 
magnitude and immediacy of the incentives were heterogeneous. 
Conclusions: The available literature on financial incentives to 
improve health-related lifestyles rarely reports on the rationale or 
background that defines the incentive approach, the magnitude of the 
incentive and other relevant details of the intervention, and the 
reporting of this information is essential to foster its use as potential 
effective interventions.
Keywords 
behavioral economics, evidence synthesis, incentives, interventions, 
non-communicable diseases, quality, systematic review, trials
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Introduction
Many non-communicable diseases require effective engage-
ment with lifestyle behaviours such as diet, physical activity 
and compliance with pharmacological medication, but this 
is difficult to achieve1. There are major benefits to be achieved 
by preventive care, including both primary and secondary pre-
vention, for example in the case of diabetes management2–5, 
yet adherence to healthy behaviors and pharmacological treat-
ment remains a challenge6–9. Financial incentives may improve 
the initiation and engagement of behaviour change to reduce 
the negative outcomes associated with non-communicable 
diseases10. The field of behavioural economics has provided 
critical insights to influence public policy11, and incentives 
are one of many tools available. Concepts such as present 
bias, loss aversion, choice overload, and reference points, 
among others, have now spread to the field of public health 
and healthcare delivery12–15.
Previous systematic reviews have focused on the effect of 
financial incentives on lifestyle behaviours16–20, with less 
attention on how the financial incentives and rewards have 
been developed. Given the growing attention to develop 
incentive-oriented interventions10, there is still a paucity in 
guidelines or recommendations that help define key aspects 
of such interventions, including the type of incentive (e.g. 
cash rewards, vouchers), the frequency and magnitude of the 
incentive, and its mode of delivery. To address this gap in the 
evidence-base, this study aimed to systematically review the 
literature on financial incentives to promote healthy lifestyle 
behaviours (e.g., physical activity) or to improve health profiles 
(e.g., HbA1c levels) with a specific interest in the meth-
odological approach used to identify how the incentive 
intervention was defined, as well as its mechanisms of delivery.
Methods
Study design
A systematic review of the literature was conducted follow-
ing the PRISMA guidelines21 (see Reporting guidelines22). 
In addition, the protocol was registered at PROSPERO on 
26 July 2018 (CRD42018102556)23. We included studies 
that: i) had adults subjects (18+ years); ii) included financial 
incentives as a broad topic, i.e., no specific types of incentives 
(e.g. cash transfers or vouchers) were sought; and iii) the 
outcome of interest was a health-related lifestyle behaviour 
(e.g., physical activity) or a risk factor for a cardiovascular 
or metabolic disease (e.g., HbA1C in diabetes patients). To 
ensure a broad range of included studies, our review focused 
on the methods of the included study, rather than on the effect 
of the financial incentive. We also did not require a specific 
comparator group for the interventions. Therefore, the search 
approach and the selection and extraction process did not 
focus on effects estimates, but on the methods, including for 
example: criteria used to define the incentive, criteria used to 
define the magnitude of the incentive, and criteria used to 
define the recipient of the incentive24.
Search
The search was conducted in OVID (MEDLINE and Embase), 
Cumulative Index to Nursing and Allied Health Literature 
(CINAHL), and Scopus from inception to March 3rd 2018. 
No language or article type restrictions were set. The search 
terms used in OVID are presented in Extended data22.
Study selection
Search results were downloaded and saved in EndNote X7 
(Clarivate, Philadelphia, PA, USA). Duplicates were elimi-
nated from the search results using EndNote duplicate refer-
ence identification. Titles and abstracts were independently 
screened by two reviewers; discrepancies between them were 
solved by a third party independently. Titles and abstracts 
selected from this first stage were sought in full-text, and 
these were studied by two reviewers independently; as before, 
discrepancies were solved by a third reviewer independently. 
These selection processes were conducted using the Rayyan 
online software25.
Data extraction
With the list of selected studies, information was extracted 
by one reviewer using a pre-specified data extraction form. 
Data extraction focused on items described in a framework used 
to document the complexity of financial incentive interven-
tions to change health behaviours created by Adams et al.24. 
In particular, the extraction form collated information about 
the study design, the methodological approach of the interven-
tion, and aspects of the financial reward used, including its 
direction, form (e.g. cash, vouchers etc), certainty (e.g. certain 
if they did something, a chance of getting something), 
frequency, immediacy, schedule, and recipient. The details of 
the reviewed studies and all data extracted during the review 
are available at Table 1 and Table 2 (see Underlying data22).
Analysis
Our review aimed to describe selected characteristics of 
intervention studies which used economic incentives to 
promote healthy lifestyle behaviours as per the framework 
described by Adams et al.24. To achieve this aim we under-
took a narrative synthesis of the included studies and aimed to 
summarise the methods followed to decide upon financial 
incentives, magnitude of the incentives, recipient of the incen-
tives, among other features of the economic incentives 
intervention. We pre-specified that we would not undertake a 
comprehensive analysis of the studies’ results (e.g., risk or impact 
estimates), including a meta-analysis, as was not the focus of our 
study. We also decided not to undertake a risk of bias assessment 
          Amendments from Version 1
Expansion in the introduction to convey key concepts and 
references from the field of behavioural economics.
Clarification on the limitations that the search strategy did not 
include economic and development databases and the search 
was conducted up to 2018.
Full citation of the studies included in the review are now 
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The search yielded 7,575 results, of which 3,656 were excluded 
after the initial screening. From 119 texts studied in detail, 
37 were included (Figure 1 summarizes the study selection 
process). All but two of the retrieved studies were conducted 
in high-income countries, with a majority in the USA (83.8%; 
31/37), and the exception were two studies from Mexico. 40.5% 
(14/37) of the studies were randomized controlled trials and 26 
(70.2%; 26/37) included more than 100 people.
Table 1 (see Underlying data22) summarises the details 
for each included study. There were a wide range of study 
populations including employees, families with school aged 
children, and low-income families. Participants had a range 
of different health conditions or risk factors, such as diabetes 
and hypertension. Interventions targeting lifestyle behav-
iors and health outcomes were also equally diverse ranging 
from group meetings with rewards, information feedback 
Figure 1. Flow diagram with the number of studies reviewed at each stage.
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from clinicians in the form of written letters, and process and 
outcome-based incentives.
Defining the rationale for the financial incentive used
Only one study described a detailed rationale for the financial 
incentive used26, and their methods involved conducting focus 
groups to understand what sort of incentives would be accept-
able for their study population. None of the other included 
studies reported a detailed methodology or rationale to 
define the magnitude of the incentive, i.e. why they gave that 
amount of money or reward. In one of the retrieved studies, 
Kranker et al.27 described that the magnitude of the incentive 
for one of the target goals was small because they considered 
such a goal (medication adherence) to be easy to achieve; in 
addition, they reported that “Incentive payments were 
moderately sized for two reasons. First, the research team 
needed to guarantee that total program costs would fall under 
a budget ceiling. Second, the research team was primarily 
interested in studying the effects of moderate financial 
incentives paired with aggressive behavior goals”.
A review of the framework used for financial incentives
Table 2 (see Underlying data22) summarises the financial 
incentives framework used for each included study. The major-
ity of included studies (83.8%; 31/37) used positive gains for 
the financial rewards, with three studies using the avoidance of a 
negative loss and three using a mixture of rewards. Cash 
or vouchers exchangeable for a range of goods or services 
were used as the financial incentive in 83.8% (31/37) of 
studies and five used specific goods or services, for example, 
health insurance discounts or diabetes test strips (see ‘Form 
of reward’, Table 2, Underlying data22). The majority 
of included studies 81.1% (30/37) used financial incentives 
that participants were certain to receive if they completed the 
required activity, five studies used a mixed approach (e.g. some 
activities were certain, but others were based upon chance), 
and one study used chance alone (see ‘Certainty’, Table 2, 
Underlying data22). In the majority of studies the recipient of 
the financial incentive was the individual study participant 
(83.8%; 31/37) with three studies providing a mixture of indi-
vidual and group rewards, and a further three studies proving 
household-based incentives (see ‘Recipient’, Table 2, Underlying 
data22).
The magnitude of the incentive varied widely from $10 up 
to and including $3000. 19/37 studies rewarded some behav-
iours, with the remaining 18 studies rewarded all incentivised 
behaviours. Just under half of the studies provided financial 
incentives immediately after an incentivized behaviour was 
undertaken (45.9%; 17/37). The remaining studies delayed 
incentives with a maximum lag of one year after the inter-
vention. Just over half (51.4%; 19/37) of studies used a fixed 
schedule for the financial incentives and 17 studies (45.9%; 17/37) 
used a variable schedule, although these were not always 
provided incrementally.
Discussion
This work aimed to systematically review the literature on finan-
cial incentives with a specific focus on the methodological 
approaches followed to define the incentive intervention, rather 
than on the effect of the intervention. In so doing, we build 
upon previous systematic reviews which have focused on 
the effect of financial incentives on lifestyle behaviours16–20, 
however less attention has been placed on how the finan-
cial incentives and rewards were developed. We found that 
whilst being key to achieve the expected results in any given 
direction, little attention has been paid to a critical aspect 
of how to design and define the best possible incentive 
strategies. The average or range earned per participant was often 
not described and whilst targets or outcomes were described, 
the achievement of the tasks depends on its difficulty. If this 
were to be compared to a pharmacological intervention, 
the field of financial incentives lacks substantial attention to 
the design of the pharmacodynamics of the drug —minimum 
and maximum doses, the most effective delivery modes to 
guarantee higher adoption, and the frequency and span-
ning of the doses to be given. Different scheme designs are 
likely to lead to different outcomes, and hence, it is impor-
tant to think about the most effective design of incentive 
schemes12, as subtle design choices in how incentives are situ-
ated, framed, or deployed can have substantial effects on their 
success12,15. Experimental data indicates that insufficient incen-
tives may paradoxically produce less motivation to engage 
with a given habit than if there were no incentive at all28. Despite 
the lack of studies reporting the methodological approaches 
taken to define the incentive intervention, there was still a 
degree of consistency across the studies in terms of the direc-
tion, form, certainty, and recipient of the financial incen-
tives used, but the magnitude and immediacy of the incentives 
were more varied.
These findings are relevant to inform checklists and other 
recommendations to improve the reporting of interventions 
and other endeavours using financial incentives. Either on the 
main manuscript, a published protocol, or on an accompanying 
scientific report, future studies should report on the ration-
ale used to derive key elements of the financial incentives. 
More detailed information about the interventions that utilize 
financial incentives, an objective that adds to the broader 
objectives of improving the quality of the reporting of health 
research, is needed to critically appraise the interventions, 
to inform the development and testing of new interventions, 
and to facilitate the implementation of these interventions 
at a larger scale, e.g., as a public health policy. We do not 
have any reasons to think that the available literature did not 
thoroughly consider the rationale of the intervention while 
planning the work, yet our findings suggest that this process 
needs to be better and more frequently reported. The develop-
ment of standardised reporting guidelines such as those used to 
report complex interventions (TIDieR)29 or trials (CONSORT)30, 
observational studies (STROBE)31 or data linkage studies 
(RECORD)32 should be developed in order to support this 
process.
Our study followed standard systematic review methods 
including a comprehensive search in four international data 
sources, but there were limitations to our approach. First, 
because of the aims and scope of our work we did not extract 
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and report on the effect estimates of the economic incen-
tives interventions. Second, we did not conduct a risk of bias 
assessment because we aimed to summarize the methodol-
ogy of the financial incentives rather than to evaluate the 
quality of the whole literature. Third, we did not search 
libraries specific for economic or behavioral sciences, which 
could have retrieved additional studies in addition to the 
health sciences databases that considers the field of health 
economics. Finally, our search was conducted up to 2018, an 
inherent limitation given the considerable dynamism in the 
field. Yet, this does not preclude the recommendation that 
guidelines for the reporting of incentive-related studies are 
needed, in particular the need for including information on 
key design features of the incentive being examined.
Our study has systematically reviewed the literature on 
financial incentives to promote healthy lifestyle behaviours 
and examined the methodological approach to identify how 
the incentive intervention was defined and its mechanisms 
of delivery. We found that studies rarely report on the rationale 
or background to define the incentive approach, the magnitude 
of the incentive and other relevant details of the intervention. 
Future studies to guide interventions and generate evidence 
about the implementation of financial incentive interventions 
are required to fill this evidence gap.
Data availability
Underlying data
Figshare: Design of financial incentive interventions to improve 
lifestyle behaviors and health outcomes: A systematic review. 
https://doi.org/10.6084/m9.figshare.14659176.v422.
This project contains the following underlying data:
- 1 Underlying data – Table 1.docx (characteristics of studies 
included in the review).
- 2 Underlying data – Table 2.docx (financial incentives 
framework summary).
Extended data
Figshare: Design of financial incentive interventions to improve 
lifestyle behaviors and health outcomes: A systematic review. 
https://doi.org/10.6084/m9.figshare.14659176.v422.
This project contains the following extended data:
- 3 Extended data – Search strategy.docx (Search terms as 
used in OVID - MEDLINE and Embase)
Reporting guidelines
Figshare: PRISMA checklist for ‘Design of financial incen-
tive interventions to improve lifestyle behaviors and health 
outcomes: A systematic review’. https://doi.org/10.6084/
m9.figshare.14659176.v422.
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC-BY 4.0).
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overweighting of small probabilities, hyperbolic discounting, increasing payoffs and 
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